key: cord-0796288-to5qwno4 authors: Maechler, Friederike; Gertler, Maximilian; Hermes, Julia; van Loon, Welmoed; Schwab, Frank; Piening, Brar; Rojansky, Shay; Hommes, Franziska; Kausch, Franka; Lindner, Andreas K.; Burock, Susen; Rössig, Heike; Hartmann, Claudia; Kirchberger, Valerie; Thieme, Alexander; Behnke, Michael; Gastmeier, Petra; Mockenhaupt, Frank P.; Seybold, Joachim title: Epidemiological and clinical characteristics of SARS-CoV-2 infections at a testing site in Berlin, Germany, March and April 2020 – A cross-sectional study date: 2020-08-20 journal: Clin Microbiol Infect DOI: 10.1016/j.cmi.2020.08.017 sha: 92812f42649ea5b64662312accc9bc18589ebbe0 doc_id: 796288 cord_uid: to5qwno4 OBJECTIVE: In Berlin, the first public SARS-CoV-2 testing site started one day after the first case in the city occured. We describe epidemiological and clinical characteristics and aim at identifying risk factors for SARS-CoV-2 detection during the first six weeks of operation. METHODS: Testing followed national recommendations, but was also based on the physician´s discretion. We related patient characteristics to SARS-CoV-2 test positivity for exploratory analyses using a cross-sectional, observational study design. RESULTS: Between March 3 and April 13, 2020, 5179 patients attended the site (median age 34 years; IQR 26-47 years). The median time since disease onset was 4 days (IQR 2-7 days). Among 4333 patients tested, 333 (7.7%) were positive. Test positivity increased up to 10.3% (96/929) during the first three weeks and then declined, paralleling Germany’s lock-down and the course of the epidemic in Berlin. Strict adherence to testing guidelines resulted in 10.4% (262/2530) test positivity, compared to 3.9% (71/1803) among patients tested for other indications. A nightclub was a transmission hotspot; 27.7% (26/94) of one night’s visitors were found positive. Smell and/or taste dysfunction indicated COVID-19 with 85.6% specificity (95%CI 82.1-88.1%). Some 4% (14/333) of those infected were asymptomatic. Risk factors for detection of SARS-CoV-2 infection were recent contact to a positive case (second week after contact, OR 3.42; 95%CI 2.48-4.71), travel to regions of high pandemic activity (e.g. Austria, OR 4.16; 95%CI 2.48-6.99), recent onset of symptoms (second week, OR 3.61; 95%CI 1.87-6.98), and an impaired sense of smell/taste (4.08; 95%CI 2.36-7.03). CONCLUSIONS: In this young population, early-onset presentation of COVID-19 resembled flu-like symptoms, except for smell and/or taste dysfunction. Risk factors for SARS-CoV-2 detection were return from regions with high incidence and contact to confirmed SARS-CoV-2 cases, particularly when tests were administered within the first two weeks after contact and/or onset of symptoms. Funding statement: No specific funding was received for this work. 24 25 Abstract: 26 Objective: In Berlin, the first public SARS-CoV-2 testing site started one day after the first case in the 27 city occured. We describe epidemiological and clinical characteristics and aim at identifying risk 28 factors for SARS-CoV-2 detection during the first six weeks of operation. 29 Methods: Testing followed national recommendations, but was also based on the physician´s 30 discretion. We related patient characteristics to SARS-CoV-2 test positivity for exploratory analyses 31 using a cross-sectional, observational study design. Since its emergence in China [1] , SARS-CoV-2 has spread at an extraordinary pace. In Germany, the 10 first case of SARS-CoV-2 infection was detected on January 27, 2020 [2] . Germany rapidly 11 implemented testing capacities for SARS-CoV-2, and the national Public Health institute (Robert 12 Koch-Institute, RKI), provided recommendations for testing [3] . Charité -Universitätsmedizin Berlin 13 opened the SARS-CoV-2 test site on Campus Virchow-Klinikum located in the north-west of Berlin 14 one day after the first COVID-19 patient was identified in the city. The site aimed to provide testing 15 for the general population, and to reduce workload for the emergency departments. Most clinical descriptions have focused on COVID-19 among hospitalized patients, with fever, fatigue, 20 dry cough, and shortness of breath as common symptoms [6] [7] [8] . Patients with mild symptoms have 21 not been investigated extensively, although this group may contribute to community transmission, 22 thereby impeding containment efforts [9, 10] . 23 The Charité test site offered the possibility to consult patients with suspicion of SARS-CoV-2 infection 24 and to assess the proportion of infected individuals among outpatients during the early epidemic. 25 The present analysis of >5000 patients aims at describing the epidemiological characteristics and the 26 clinical manifestation of SARS-CoV-2 infection to identify factors associated with SARS-CoV-2 27 detection in an outpatient setting. 28 29 The first COVID-19 case in Berlin was identified on March 2, 2020. The test site commenced 31 operations on March 3, 2020, with opening hours from 8:00 to 16:00 (20:00). 32 Upon presentation, physicians interviewed patients via an intercom with visual contact through 33 window screens. Taking of medical history and assessment of symptoms were guided by a 34 questionnaire also available as a web application "CovApp"(https://covapp.charite.de/). If indicated, 35 a combined oro-and nasopharyngeal swab was obtained and tested for SARS-CoV-2 using reverse 36 transcriptase polymerase chain reaction (RT-PCR) in the central hospital laboratory [11] . Other 37 respiratory pathogens were not tested, and patients were not examined physically. 38 The decision on testing largely followed RKI recommendations, which changed over time. Until 39 March 23, 2020, they comprised mainly symptomatic individuals either with contact to SARS-CoV-2 40 cases, or with return from an area of risk, as determined and continuously redefined by the RKI, 41 within 14 days before disease. As of March 24, only individuals with acute respiratory symptoms with 42 contact to confirmed SARS-CoV-2 cases, or without contact depending on risk factors including 43 occupation, age and underlying clinical conditions remained, please see the Appendix for details. If 1 test capacity was sufficient, acute respiratory symptoms alone justified testing, and ultimately, 2 testing was based on the attending physician´s discretion. Usage of the test site was also influenced 3 by the implementation of video consultations and an ordinance on contact restrictions effective 4 March 23, 2020, stating that persons "shall stay in their home at all times". 5 For the present analysis, ethical approval was obtained from Charité´s institutional review board 6 (EA4/083/20). Data width and granularity differed partially between patients, because the 7 designated risk areas were modified over time and impaired sense of smell/taste was added as 8 symptom. Data were continuously entered into the hospital information system. After extraction, 9 data were pseudonomyzed for analysis. The clinical picture of patients who tested positive was, though still mild, relatively more severe, with 16 higher proportions of body aches, chills, fatigue, fever, headache and rhinorrhea (Table2, Figure2) . 17 SARS-CoV-2 positive patients showed an increased proportion of affected sense of smell/taste 18 compared to patients who tested negative, but 72.4% (21/29) also showed symptoms of rhinorrhea. 19 Chemosensory dysfunction was the only symptom with some use to differentiate between SARS-20 CoV-2 infection and other respiratory illness with 85.6% specificity (95%CI, 82. The probability to detect SARS-CoV-2 was influenced by patient factors, symptomatology, and travel 8 to high prevalence countries, but also by time since disease onset or last contact to confirmed cases. 9 Sensitivity analyses for the first four and last four weeks confirmed the main findings from primary 10 analysis (Appendix TableS1). Separate models for factors supposedly on the causal pathway, for the 11 entire 6 weeks and also broken down to the first and last four weeks identified the same risk factors, 12 except for a protective effect for Charité employees (Appendix TableS2) . Risk factors associated with 13 exposure were more pronounced in the first four weeks, before the test recommendations changed 14 and contact restrictions were imposed (Appendix TableS1 and TableS2) In this description of SARS-CoV-2 infected individuals from the early epidemic in Berlin, Germany, 2 most patients were young and showed mild symptoms of a respiratory tract infection. Important risk 3 factors for detection of SARS-CoV-2 infection were recent contact to a positive case, travel to 4 designated areas of risk, recent onset of symptoms, symptoms including impaired sense of 5 smell/taste and unspecific symptoms such as fever, chills and body aches. 6 As of April 14, Berlin counted 4,668 cases [12], 333 of which had been identified at the Charité test 7 site (7%). If we had tested patients strictly according to RKI recommendations, more than 20% of 8 SARS-CoV-2 infected individuals attending the site would have been missed and could have 9 contributed to additional silent community transmission. This illustrates the delicate balance 10 between efficient use of limited resources vs. broadening test indications to identify otherwise 11 undetected carriers. 12 Travelling abroad was a risk factor for SARS-CoV2 infection, particularly in the weeks following winter 13 holidays in February. Among risk areas as determined by RKI, returnees from Austria, a popular 14 destination for winter sports, had a four times increased chance to have a positive test result. 15 Anecdotally, a single bar in an Austrian ski resort was a transmission hotspot, which only became 16 apparent with increasing numbers of sick returnees [13, 14] . In contrast, extensive media coverage 17 on the COVID-19 tragedy in Italy might have alerted the public and caused returnees from non-18 affected Italian regions to attend the test site. This could explain why returnees from a country with 19 a high case number had reduced odds of infection. 20 Unsurprisingly, exposure to COVID-19 cases was associated with SARS-CoV2 infection. However, a 21 considerable number of exposed patients tested negative, including household members. As contact 22 persons are usually tested once and tests could be realized either too early or too late to detect viral 23 RNA, negative test results should be interpreted carefully. Secondary-attack rates for household 24 members have been estimated around 16% [15] . The extent of individual variation in the number of 25 secondary cases (dispersion) may be substantial, but is yet undetermined [16] . The transmission 26 events within one crowded nightclub support temporary lock-down strategies and stress the 27 importance of rapid contact tracing in potential superspreading events and isolation of cases without 28 waiting for screening results to contain the outbreak. 29 The clinical suspicion of SARS-CoV-2 infection based on symptoms proved virtually impossible, as the 30 pandemic reached Berlin during the peak of influenza and cold season [17] . Almost two thirds of 31 patients presented with cough, but respiratory symptoms did not predict positive test results. Only 32 an impaired sense of smell/taste was clearly increased among SARS-CoV-2 infected patients, 33 confirming olfactory disorders as potential early symptom of COVID-19 patients [18, 19] . We may 34 have found symptoms more specific of SARS-CoV-2 if we had compared to other diseases, which was 35 beyond the scope of the test site. 36 In our patients, the proportion of asymptomatic cases was relatively small, contrasting higher 37 numbers reported elsewhere [20] . One obvious explanation is the largely symptom-based screening. 38 However, more than one in four among hospital staff was asymptomatic upon presentation, 39 indicating the risk of undetected nosocomial transmission. 40 Symptom/risk-based screening screening is widely used to contain the epidemic [23] and may yield 41 more diagnoses compared to a less restricted strategy, but detection of SARS-CoV-2 clearly 42 depended on the time since the symptoms began. Some patients may have been tested beyond the 43 detection period, as viral RNA concentrations appear to decline rapidly after infection, and could fall 44 below detection thresholds after day 5 of disease onset [21] . Considering the threat posed by silent 45 transmission through asymptomatic carriage, less restricted screening approaches may be crucial to 1 interrupt transmission chains with potentially dramatic consequences if health care staff or potential 2 superspreaders are affected. Because screening without repeated sampling in persons tested 3 negative may lead to a false sense of security, especially in settings with a high pre-test probability, 4 targeted screening programs at potential transmission hubs such as personnel in long term care 5 facilities or schools should encompass repeated sampling. Sentinel surveillance based on symptoms 6 and/or absence from work, school or kindergartens could complement laboratory-based test 7 strategies, speed-up detection of clusters, and trigger public health action, e.g. partial school 8 closures, contact tracing and targeted testing. 9 There are limitations to our findings' validity and representativeness. The patient population may 10 have changed over time, as did testing recommendations. Initial media reports on long waiting times 11 and contact restrictions might have prevented patients from consulting the test site. Some patients 12 could have exaggerated sympoms to obtain a test, while others may have been denied testing before 13 they developed symptoms. 14 15 These data from the first operational SARS-CoV-2 test site in Berlin illustrate the predominantly mild 17 disease resembling common cold or influenza among outpatients. Impaired sense of smell/taste may 18 have value as a clinical symptom to guide decision on whether or not to test patients, but warrants 19 further evaluation. The absence of severe cases might result from the outpatient setting, the early 20 phase of the epidemic, access to testing, and the young patient population. 21 Typical risk factors such as travel to high incidence regions, contact to positive individuals, and 22 gatherings were identified for the majority of the patients, whereas the source of infection remained 23 unsolved for others. The impact of a single spreading event (nightclub) on the early case count in 24 Berlin cautions against using premature data for extrapolating figures. In light of potential 25 transmission from mildly symptomatic and asymptomatic infected persons, potential superspreading 26 events should entail rapid contact tracing and subsequent isolation regardless of testing, which may 27 be a slow and insecure tool if the chance for contacts to be infected is high. 28 All screening strategies depend on public acceptance, access to and usage of testing capacities, and 29 testing recommendations, among other factors. Broad-scale testing targeted at high risk populations 30 such as travel returnees from high incidence regions and contacts to confirmed cases should be 31 scheduled ideally within the first two weeks after contact and/or onset of symptoms. 32 33 34 1 We thank all medical and non-medical Charité staff who contributed to the rapid and effective 2 implementation of patient management, testing and data-collection at SARS-CoV-2-testing site 3 Charité - Crude odds ratio and 95% confidence interval J o u r n a l P r e -p r o o f A Novel Coronavirus from Patients with 1 Pneumonia in China Transmission of 3 2019-nCoV Infection from an Asymptomatic Contact in Germany. The New England journal of 4 medicine COVID-19-Verdacht: Maßnahmen und Testkriterien Clinical features of patients infected with 10 2019 novel coronavirus in Wuhan Early lessons from the frontline of the 2019-nCoV outbreak Epidemiological and clinical 14 characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive 15 study Clinical Characteristics of Coronavirus 17 Disease 2019 in China Clinical Characteristics of 138 Hospitalized 19 Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan Protecting health-care workers from 21 subclinical coronavirus infection. The Lancet Respiratory medicine Clinical characteristics of 24 asymptomatic 23 infections with COVID-19 screened among close contacts in Nanjing, China. Science China Life 24 sciences Detection of 2019 26 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro surveillance : bulletin Europeen sur les 27 maladies transmissibles = European communicable disease bulletin Apres-ski: The spread of coronavirus from ischgl through 31 germany. Covid Economics: Vetted and Real-Time Papers A cascade of causes that led to the COVID-19 tragedy in Italy and in other European 33 Union countries The characteristics of household transmission 35 of COVID-19. Clinical infectious diseases : an official publication of the Infectious Diseases Society of 36 America Pattern of early human-to-human transmission of Wuhan Presentation of new onset anosmia during the COVID-19 42 pandemic Neurologic Manifestations of Hospitalized 44 Patients With Coronavirus Disease Estimating the asymptomatic proportion of 46 coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship Euro surveillance : bulletin Europeen sur les maladies transmissibles = European 48 communicable disease bulletin Virological 50 assessment of hospitalized patients with COVID-2019